US 8828936
Therapeutic use of SCGB3A2
granted A61KA61K38/1709A61K38/18
Quick answer
US patent 8828936 (Therapeutic use of SCGB3A2) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/1709, A61K38/18, A61P, A61P11/00